|
Real-time Estimate
Tradegate
11:51:41 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 57.75 EUR | -0.35% |
|
-1.70% | -9.13% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.35% | -1.70% | +6.56% | -1.54% | -9.13% | +0.79% | +19.21% | -9.28% | +332.21% | 3.43B | |
| -2.39% | -0.47% | +0.94% | +17.44% | +9.82% | +68.30% | +116.05% | +337.19% | +1,378.16% | 1,052B | |
| -0.66% | +0.43% | +4.15% | +14.84% | +25.80% | +47.39% | +51.02% | +46.40% | +116.36% | 627B | |
| -0.54% | +1.39% | -1.94% | +18.57% | +9.18% | +20.69% | +64.61% | +110.67% | +273.78% | 441B | |
| +0.01% | -4.82% | +6.25% | +10.38% | +8.20% | +38.71% | +37.66% | -4.03% | +45.53% | 349B | |
| +0.41% | -3.12% | -1.73% | +4.81% | +12.08% | +22.57% | +36.70% | +41.62% | +56.38% | 287B | |
| +1.11% | -3.44% | -8.07% | -15.55% | -16.04% | -1.36% | +7.28% | +34.86% | +128.41% | 241B | |
| -0.63% | +1.04% | +11.74% | +27.24% | +26.86% | +40.05% | +56.67% | +79.69% | +141.18% | 224B | |
| -0.49% | -4.10% | -11.00% | +2.66% | -9.73% | -15.51% | -53.94% | -11.30% | +89.85% | 202B | |
| +0.16% | +3.87% | +1.51% | +6.78% | +12.73% | +16.89% | +77.38% | +92.94% | +74.59% | 172B | |
| -0.04% | +0.11% | +6.56% | +5.76% | +7.59% | +6.56% | -24.49% | -45.23% | -23.00% | 153B | |
| -1.27% | -1.38% | +5.49% | +11.98% | +18.34% | +31.77% | +4.76% | -7.06% | +7.44% | 130B | |
| -2.07% | +1.95% | +4.06% | +15.75% | +11.56% | +28.76% | +47.27% | +164.83% | +405.75% | 128B | |
| +0.69% | +0.68% | -1.68% | +2.29% | -8.08% | -11.15% | -22.15% | -14.84% | +8.55% | 105B | |
| +1.13% | -4.73% | -4.19% | -2.14% | +0.65% | +27.61% | +35.24% | -3.12% | -12.58% | 98.67B | |
| -1.00% | -3.49% | -6.29% | -12.95% | -16.73% | +9.65% | +60.71% | +68.69% | +492.58% | 71.68B | |
| -1.75% | -1.24% | +0.60% | +5.03% | +14.02% | +22.89% | +24.19% | +51.00% | +17.55% | 56.3B | |
| -0.03% | -3.09% | -1.55% | +26.12% | +28.91% | +72.43% | -7.05% | -0.31% | -50.12% | 54.36B | |
| -2.12% | -3.66% | -6.02% | -2.54% | -11.67% | -17.00% | +28.31% | -6.82% | +213.20% | 51.37B | |
| +0.68% | +3.99% | +14.12% | +7.23% | +17.81% | +105.88% | +290.34% | +277.52% | -31.64% | 42.85B | |
| Average | -0.17% | -0.73% | +0.98% | +7.11% | +6.61% | +25.80% | +42.49% | +60.17% | +183.21% | 224.49B | |
| Weighted average by Cap. | +0.25% | -0.65% | +1.03% | +11.22% | +9.98% | +35.44% | +54.90% | +114.44% | +414.82% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
